BOSTON (Reuters) - Oracle Corp said on Friday it agreed to spend $685 million to buy Phase Forward Inc, the top maker of programs that help drugmakers run clinical trials, in Oracle's biggest software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback